Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 3—March 2022
Synopsis

Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa)

Andrew Fox-LewisComments to Author , Felicity Williamson, Jay Harrower, Xiaoyun Ren, Gerard J.B. Sonder, Andrea McNeill, Joep de Ligt, and Jemma L. Geoghegan
Author affiliations: Counties Manukau District Health Board, Auckland, New Zealand (A. Fox-Lewis); Auckland District Health Board, Auckland (F. Williamson, J. Harrower); Institute of Environmental Science and Research, Porirua, New Zealand (X. Ren, G.J.B. Sonder, A. McNeill, J. de Ligt, J.L. Geoghegan); University of Amsterdam, Amsterdam, the Netherlands (G.J.B. Sonder); University of Otago, Dunedin, New Zealand (J.L. Geoghegan)

Main Article

Figure 3

Unrooted maximum-likelihood phylogenetic tree of genomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from persons A, B, C, D, and E, implicated in airborne transmission of SARS-CoV-2 Delta variant between separate nonadjacent rooms within a tightly monitored managed isolation facility, New Zealand, set among a background of other lineage B.1.617.2 (Delta variant) genomes sampled from around the world during July 1–14, 2021. Colored circles indicate persons A–E. Person F is not included because they were not infected with SARS-CoV-2 during the timeframe of this investigation. Upper left phylogenetic scale bar indicates number of nucleotide substitutions per site. Lower right scale shows number of mutations (single nucleotide polymorphisms) difference between viral sequences isolated from persons A, B, C, D, and E.

Figure 3. Unrooted maximum-likelihood phylogenetic tree of genomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from persons A, B, C, D, and E, implicated in airborne transmission of SARS-CoV-2 Delta variant between separate nonadjacent rooms within a tightly monitored managed isolation facility, New Zealand, set among a background of other lineage B.1.617.2 (Delta variant) genomes sampled from around the world during July 1–14, 2021. Colored circles indicate persons A–E. Person F is not included because they were not infected with SARS-CoV-2 during the timeframe of this investigation. Upper left phylogenetic scale bar indicates number of nucleotide substitutions per site. Lower right scale shows number of mutations (single nucleotide polymorphisms) difference between viral sequences isolated from persons A, B, C, D, and E.

Main Article

Page created: December 22, 2021
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external